Last update 05 Jul 2025

YL-10069

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
SGLT2
Action
inhibitors
Mechanism
SGLT2 inhibitors(Sodium/glucose cotransporter 2 inhibitors)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Shanghai Yingli Pharmaceutical Co., Ltd.Shanghai Yingli Pharmaceutical Co., Ltd.
Active Organization
Shanghai Yingli Pharmaceutical Co., Ltd.Shanghai Yingli Pharmaceutical Co., Ltd.Shanghai Institute of Pharmaceutical IndustryShanghai Institute of Pharmaceutical Industry
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with YL-10069
CTR20190388
/ Active, not recruitingPhase 1
单中心、随机、双盲、单次给药、剂量递增、安慰剂对照评价YL-10069片在中国健康受试者中的I期临床试验
[Translation] A single-center, randomized, double-blind, single-dose, dose-escalation, placebo-controlled phase I clinical trial evaluating YL-10069 tablets in healthy Chinese subjects
100 Clinical Results associated with YL-10069
Login to view more data
100 Translational Medicine associated with YL-10069
Login to view more data
100 Patents (Medical) associated with YL-10069
Login to view more data
100 Deals associated with YL-10069
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 1
China
Shanghai Yingli Pharmaceutical Co., Ltd.Shanghai Yingli Pharmaceutical Co., Ltd.
26 Feb 2019
Diabetes Mellitus, Type 2Phase 1
China
Shanghai Institute of Pharmaceutical IndustryShanghai Institute of Pharmaceutical Industry
26 Feb 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free